Frédéric Gervais

2.1k total citations
26 papers, 428 citations indexed

About

Frédéric Gervais is a scholar working on Geriatrics and Gerontology, Artificial Intelligence and Computational Theory and Mathematics. According to data from OpenAlex, Frédéric Gervais has authored 26 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 8 papers in Artificial Intelligence and 4 papers in Computational Theory and Mathematics. Recurrent topics in Frédéric Gervais's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Advanced Software Engineering Methodologies (5 papers) and Formal Methods in Verification (4 papers). Frédéric Gervais is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Advanced Software Engineering Methodologies (5 papers) and Formal Methods in Verification (4 papers). Frédéric Gervais collaborates with scholars based in France, Canada and United States. Frédéric Gervais's co-authors include Peter Clausing, Vicente Nogués, Gerd Bode, Jennifer Sims, Marc Frappier, Richard St‐Denis, Véronique Baron‐Bodo, C Fisch, Philippe Moingeon and Laurent Mascarell and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Alzheimer s Disease.

In The Last Decade

Frédéric Gervais

22 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Gervais France 8 111 49 46 43 39 26 428
G Pabst Germany 12 77 0.7× 59 1.2× 45 1.0× 34 0.8× 39 1.0× 48 596
Anwar Husain United States 10 147 1.3× 59 1.2× 20 0.4× 26 0.6× 14 0.4× 17 383
Mirjam N. Trame United States 14 83 0.7× 38 0.8× 43 0.9× 8 0.2× 60 1.5× 33 504
Ronilda D’Cunha United States 10 55 0.5× 18 0.4× 61 1.3× 41 1.0× 24 0.6× 27 338
Benjamin Weber United States 14 188 1.7× 45 0.9× 61 1.3× 13 0.3× 73 1.9× 34 870
Kazuyoshi Kawakami Japan 17 150 1.4× 76 1.6× 84 1.8× 20 0.5× 32 0.8× 74 883
Madhusudana R. Chaluvadi United States 6 74 0.7× 27 0.6× 48 1.0× 26 0.6× 71 1.8× 9 430
Alison E. Aitken United States 6 160 1.4× 43 0.9× 92 2.0× 47 1.1× 74 1.9× 6 767
Sam Liao United States 14 80 0.7× 45 0.9× 158 3.4× 42 1.0× 42 1.1× 27 695
Julie Bertrand France 15 70 0.6× 34 0.7× 23 0.5× 37 0.9× 56 1.4× 43 736

Countries citing papers authored by Frédéric Gervais

Since Specialization
Citations

This map shows the geographic impact of Frédéric Gervais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Gervais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Gervais more than expected).

Fields of papers citing papers by Frédéric Gervais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Gervais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Gervais. The network helps show where Frédéric Gervais may publish in the future.

Co-authorship network of co-authors of Frédéric Gervais

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Gervais. A scholar is included among the top collaborators of Frédéric Gervais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Gervais. Frédéric Gervais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraser, Kathryn, Frédéric Gervais, Mark Aspinall-O’Dea, et al.. (2025). Applications of Cell-Based Protein Array Technology to Preclinical Safety Assessment of Biological Products. Toxicologic Pathology. 53(1). 31–44. 1 indexed citations
4.
Cransac, Amélie, et al.. (2022). Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study. International Journal of Clinical Pharmacy. 44(4). 922–929. 1 indexed citations
6.
Gervais, Frédéric, et al.. (2022). Amino Acid Solutions for 177Lu-Oxodotreotide Premedication: A Tolerance Study. Cancers. 14(21). 5212–5212. 4 indexed citations
7.
Pongan, Élodie, et al.. (2021). Pretransplant Comprehensive Geriatric Assessment in Older Patients with Advanced Chronic Kidney Disease. ˜The œNephron journals/Nephron journals. 145(6). 692–701. 14 indexed citations
8.
Maxeiner, Joachim, Rahul Sharma, Frédéric Gervais, et al.. (2021). Genomics Integrated Systems Transgenesis (GENISYST) for gain-of-function disease modelling in Göttingen Minipigs. Journal of Pharmacological and Toxicological Methods. 108. 106956–106956. 4 indexed citations
9.
Gervais, Frédéric, et al.. (2021). Drug-related problems among older patients: Analysis of 8 years of pharmacist's interventions. Annales Pharmaceutiques Françaises. 79(5). 511–521. 5 indexed citations
10.
Gervais, Frédéric, et al.. (2021). Drug-related problems in older patients with advanced chronic kidney disease identified during pretransplant comprehensive geriatric assessment. Néphrologie & Thérapeutique. 18(1). 45–51. 3 indexed citations
11.
Gervais, Frédéric, et al.. (2020). Medication exposure and frailty in older community-dwelling patients: a cross-sectional study. International Journal of Clinical Pharmacy. 42(2). 508–514. 14 indexed citations
12.
Gervais, Frédéric, et al.. (2019). Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework. Toxicologic Pathology. 47(4). 436–443. 10 indexed citations
13.
Gervais, Frédéric, et al.. (2018). Pharmacists’ interventions on prescription problems in one French community pharmacy: A prospective pilot study. Annales Pharmaceutiques Françaises. 76(4). 299–305. 10 indexed citations
14.
Gervais, Frédéric, et al.. (2018). Intranodal Angiomyomatous Hamartoma in a Cynomolgus Monkey. Toxicologic Pathology. 47(2). 190–195. 2 indexed citations
15.
16.
Frappier, Marc, et al.. (2016). Formal refinement of extended state machines. SHILAP Revista de lepidopterología. 209. 1–16.
17.
Slimano, Florian, et al.. (2014). L’internat en pharmacie hospitalière en France à l’horizon 2014 : vers une formation reconnue ?. Annales Pharmaceutiques Françaises. 72(5). 317–324. 2 indexed citations
18.
Frappier, Marc, et al.. (2011). Enforcing ASTD Access-Control Policies with WS-BPEL Processes in SOA Environments. RePEc: Research Papers in Economics. 2(2). 37–59. 2 indexed citations
19.
Bode, Gerd, et al.. (2010). The utility of the minipig as an animal model in regulatory toxicology. Journal of Pharmacological and Toxicological Methods. 62(3). 196–220. 287 indexed citations
20.
Gervais, Frédéric, Marc Frappier, & Régine Laleau. (2008). Generating relational database transactions from eb 3 attribute definitions. Software & Systems Modeling. 8(3). 423–445. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026